Promega Replaces Production Site with New Shanghai Facility

Life Science Investing News

Asian Scientist Magazine reported that Promega Corp., a life sciences manufacturer, replaced a molecular biology reagent production site with a new facility in Shanghai, China last week. The company bought the new building in June, and 40 scientists, technicians and administrators will start work there over the next several weeks.

Asian Scientist Magazine reported that Promega Corp., a life sciences manufacturer, replaced a molecular biology reagent production site with a new facility in Shanghai, China last week. The company bought the new building in June, and 40 scientists, technicians and administrators will start work there over the next several weeks.

As quoted in the market news:

The new site … provides additional research, development, and cGMP manufacturing capabilities for molecular diagnostics products for the Chinese market.

The new facility, called the Shanghai Promega Life Science Center, is one of five Promega manufacturing sites worldwide. Together these facilities manufacture biological and chemical reagents and instruments used in both life science research and molecular diagnostics. Promega products are manufactured under certified quality systems that meet the requirement of ISO 9001 or ISO 13485, depending on product intended use.

Click here to read the full Asian Scientist Magazine report.

The Conversation (0)
×